Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...

Yahoo FinanceOct 10 05:52

Baird Maintains Lineage Cell Therapeutics(LCTX.US) With Buy Rating, Maintains Target Price $5

Futu NewsOct 2 02:32 · Ratings

Express News | Opregen® (Rg6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (Isscr) 2024 Copenhagen International Symposium

BreakingsSep 25 20:00

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance, at the 59th Annual Inner Ear Biology Workshop

BusinesswireSep 18 20:00

Craig-Hallum Initiates Lineage Cell Therapeutics at Buy With $4 Price Target

MT NewswiresAug 21 17:28 · Ratings

Lineage Cell Therapeutics Analyst Ratings

BenzingaAug 20 20:45 · Ratings